Marvell Technology Stock Nears Perfect IBD Composite Rating

Marvell Technology (MRVL) saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96. This move pushes Marvell Technology stock closer to a perfect 99 score.


The new score tells you the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria. History shows the top market performers tend to have a 95 or higher score as they launch their major moves.

Is Marvell Technology Stock A Buy?

Marvell Technology is now out of buy range after clearing the 41.44 entry in a flat base.

Looking For Winning Stocks? This 3-Step Routine

Marvell Technology stock sports an 89 EPS Rating, which means the Bermuda-domiciled chipmaker’s recent quarterly and annual earnings growth is outpacing 89% of all stocks.

Its Accumulation/Distribution Rating of B for Marvell Technology stock shows moderate buying by institutional investors over the last 13 weeks.

In Q3, the company posted 47% earnings growth. That means it’s now generated four straight quarters of rising EPS gains. Top-line growth climbed 13%, up from 11% in the prior quarter. The company has now posted increasing growth in each of the last four quarters.

Marvell Technology stock earns the No. 6 rank among its peers in the Electronics-Semiconductor Fabless industry group. Inphi (IPHI), Monolithic Power Systems (MPWR) and Advanced Micro Devices (AMD) are among the top five highly rated stocks within the group.


MarketSmith’s Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

IBD Stock Rating Upgrades: Rising Relative Strength

Source Article